QQ客服 官方微博 反馈留言

	Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial
	Lai Wei; Seng Gee Lim; Qing Xie; Kính Nguyen Văn; Teerha Piratvisuth; Yan Huang; Shanming Wu; Ming Xu; Hong Tang; Jun Cheng
刊名	The Lancet Gastroenterology & Hepatology
	2019
卷号	Vol.4 No.2页码:127-134
ISSN号	2468-1253
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1819055
专题	四川大学
作者单位	1.National Hospital for Tropical Diseases, Hanoi, Vietnam 2.Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China f Xiangya Hospital, Central South University, Changsha, Hunan, China 3.National University Hospital, Singapore a Peking University People's Hospital, Beijing, China 4.Songklanagarind Hospital, Songkla, Thailand h Guangzhou No 5.ae People's Hospital 115, Ho Chi Minh City, Vietnam ad The People's Hospital of Hainan Province, Haikou, Hainan, China ac The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China y Siriraj Hospital, Mahidol University, Bangkok, Thailand z The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China aa King Chulalongkorn Memorial Hospital, Bangkok, Thailand ab The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China u Gilead Sciences, Foster City, CA, USA v The Second Hospital of Nanjing, Affiliated to South East University, Nanjing, Jiangsu, China w Bach Mai Hospital, Hanoi, Vietnam x Peking University First Hospital, Beijing, China ag The Second Xiangya Hospital of Central South University, Changsha, China t Hospital Tengku Ampuan Afzan, Kuantan, Pahang, Malaysia af Henan Province People's Hospital, Zhengzhou, Henan, China ai The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China ah Jiangsu Province People's Hospital, Nanjing, Jiangsu, China ak University Malaya Medical Centre, Kuala Lumpur, Malaysia aj Beijing You-An Hospital, Capital Medical University, Beijing, China am Beijing Friendship Hospital Affiliate of Capital, Beijing, China al Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China 6.People's Hospital, Guangzhou, Guangdong, China r Singapore General Hospital, Singapore g Shanghai Public Health Clinical Centre, Shanghai, China s Tongji Hospital Affiliated to Tongji Medicine College, Huazhong University of Science and Technology, Wuhan, Hubei, China p Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand i West China Hospital, Sichuan University, Chengdu, Sichuan, China q The 3rd Hospital of Hebei Medical University, Shijiazhuang, Hebei, China n Ramathibodi Hospital, Mahidol University, Bangkok, Thailand o Shengjing Hospital of China Medical University, Shenyang, Liaoning, China l The First Hospital of Jilin University, Changchun, Jilin, China m Jinan Infectious Disease Hospital, Jinan, Shandong, China j Beijing Ditan Hospital, Beijing, China k Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
推荐引用方式 GB/T 7714	Lai Wei,Seng Gee Lim,Qing Xie,et al. Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial[J]. The Lancet Gastroenterology & Hepatology,2019,Vol.4 No.2:127-134.
APA	Lai Wei.,Seng Gee Lim.,Qing Xie.,Kính Nguyen Văn.,Teerha Piratvisuth.,...&Jidong Jia.(2019).Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial.The Lancet Gastroenterology & Hepatology,Vol.4 No.2,127-134.
MLA	Lai Wei,et al."Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial".The Lancet Gastroenterology & Hepatology Vol.4 No.2(2019):127-134.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。